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Review
The first incarnation of the national rare donor panel 
(NRDP) in the United Kingdom was established in 1952, 
when 1800 donors (100 from each of the 18 blood transfusion 
centers around the UK) were fully typed by the International 
Blood Group Reference Laboratory (IBGRL) in London, 
to enable the UK Blood Transfusion Services to meet the 
demands for patients with what were considered special and 
rare blood types.1 What was considered a rare type in 1952 
was very different than what is perceived as a rare type today, 
however. The purpose of the panel was to provide blood for 
patients whose serum contained antibodies that made finding 
compatible blood difficult. Therefore, although the definition of 
a rare blood type has changed significantly, the core purpose 
of the NRDP has remained the same.
In 1967, coinciding with the development of the World 
Health Organization (WHO) International Rare Donor Panel 
(IRDP),2 the IBGRL revised the NRDP by removing donors 
with what were now considered relatively common blood 
types and adding donors with blood types of great rarity.
In the late 1970s, a mass screening program using 
microplate methodology was initiated at the National Blood 
Service South London center to identify donors whose cells 
lacked high-prevalence antigens. This screening program has 
developed over the years to include additional antigens and 
provides the largest source of rare donors in the UK.
The UK NRDP consists of all the rare donor categories 
included on the IRDP, with the addition of the following: 
r ŕ´ K–; r´́ r´́  K–; R1R1 k–; R2R2 k–; and rr k–. Although not 
considered rare by IRDP criteria, these phenotypes are difficult 
to find in the UK.
The Current Panel
The current UK NRDP consists of approximately 2000 
active donors. In the period from April 2012 to the end of 
March 2014, 540 new rare donors were added to the panel. 
In the same period, 216 rare units were issued for clinical 
use; 174 of those units were for patients within the UK and 
the remaining 42 units were shipped internationally. Only two 
rare blood requests could not be filled: one for In(b–) units 
and the other for e–, S–s–U– units; both were international 
requests.
The UK National Frozen Blood Bank
A selection of rare units are frozen and stored at the UK 
National Frozen Blood Bank (NFBB), which is situated at 
the National Health Service Blood and Transplant (NHSBT) 
Liverpool center. A special code applied to the database record 
of rare donors ensures that when they donate, their units are 
flagged for possible freezing, separated from general blood 
stocks, and processed as rare units. Donations are sent to the 
NFBB from all the NHSBT centers across England and also 
from several regular rare donors from the Scottish and Welsh 
blood services.
Red blood cell (RBC) units are frozen using a high-glycerol, 
automated method (ACP 215, Haemonetics, Glasgow, UK). 
Upon freezing, units are stored between –60°C and –80°C 
and given a shelf life of 10 years. For some more exquisitely 
rare phenotypes, the units may be kept beyond the assigned 
expiry, especially if there are no known donors of that type 
currently available.
As of March 2014, the NFBB had approximately 600 
frozen rare units. Over the past 9 years, the NFBB averaged 
around 120 units frozen and 90 units thawed per year (Gina 
MacLaren, personal communication, June 17, 2015).
How We Find Rare Donors
The main method of finding rare donors in the UK is 
through screening programs, using predominantly serologic 
methods. The main program carried out at the NHSBT 
South London center screens donations in batches of 640 
using a method based on the microplate method described 
by Gale, Rowe, and Northfield.3 Only donations from 
previously unscreened donors are selected for testing. These 
are predominantly group O, but also some group A donors 
are selected. Table 1 shows the current screening undertaken 
at the South London center. Samples from donors identified 
as having a rare phenotype are then sent to the IBGRL for 
confirmation testing.
In addition to this mass screening, all K+ donations 
identified through routine donation testing are typed for k. For 
many years (until 1995), the Welsh blood service screened a 
portion of their donors for Lub, Kpb, Yta, Coa, and Vel.4 They 
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now screen approximately 90 donations a week for Lua, Lub, 
Kpa, Kpb, and k (Heather Davies, personal communication, 
April 30, 2015). Routine Rh typing (D, C, c, E, e) facilitates the 
detection of r′r′, r″r″, Rhnull, D– –, and other Rh variants. Oh 
phenotype donors are detected via anomalous ABO grouping 
results, and other rare phenotypes such as Jk(a–b–), Fy(a–b–), 
and S–s–U– are detected through routine extended typing 
strategies. The routine antibody screening test, carried out on 
all donations, can also lead to the detection of rare donors—for 
example, the rare p and Pk phenotypes are identified through 
their associated antibodies that are present in the serum of 
such individuals. Similarly, a small portion of rare donors 
are former patients, ascertained as lacking a high-prevalence 
antigen because of the presence of the corresponding antibody 
in their serum.1 When such a patient is identified and his or her 
health permits, efforts are made to recruit this individual as a 
donor and also to recruit family members of this individual, 
especially siblings, in the hope of finding additional donors 
with the same rare phenotype.
Incompatible Transfusion Cases
Data regarding transfusion of incompatible units in rare 
cases was not actively collected in the UK until more recently 
and still continues to be difficult to obtain. From April 2012 to 
the end of March 2014, one case of incompatible transfusion 
was reported to the NHSBT (Dr. Nay Win, personal 
communication, May 27, 2014). A pregnant patient with 
thalassemia intermedia presented with weak anti-Jra (and 
weak anti-CW) in her serum. Intravenous immunoglobulin was 
administered at 0.4g/kg/day for 3 days prior to transfusion 
of 2 units of Jr(a+) RBCs and the RBCs were tolerated well. 
Delivery was by caesarean section due to intrauterine fetal 
growth restriction. There were no signs of hemolytic disease 
of the fetus and newborn.
Incentives for Rare Donors
The blood supply in the UK is sustained through the 
generosity of non-remunerated, voluntary blood donors. This 
situation helps to maintain the safest possible blood supply 
and, to that effect, there are no incentives offered to rare 
blood donors in the UK. When a donor is identified as having 
a rare blood type, the person receives a letter explaining the 
uniqueness and importance of his or her blood. Consent is 
also requested for the addition of the donor to the NRDP and 
IRDP. The letter also provides information that the donor may 
be called upon in special situations to donate for particular 
patients. Rare donors are asked to actively encourage any 
eligible family members to become blood donors. They may be 
given special consideration regarding donation appointment 
times, and every effort is made to make an appointment 
available when it is most convenient for them, including 
creating additional appointment slots.
If blood from a rare donor is identified as being required 
for a particular patient, and the donor is assessed as being 
eligible to donate, the donor will receive a phone call from a 
dedicated rare donor consultant hematologist and asked if he 
or she is able to give blood on this occasion. Our rare donors 
understand the importance of being available to donate when 
they receive the call, and we are grateful for their willingness 
to go out of their way to save and improve the lives of others, 
especially when called upon to do so at short notice.
Rhnull Donors
Only one UK donor with the extremely rare Rhnull 
phenotype is currently known. The donor was identified in 
2003 and shortly after being discovered was contacted to 
donate a unit of blood for urgent shipment to Portugal for life-
saving transfusion to a newborn.5 The donor has the regulator 
type of Rhnull, genotype RHCE*ce/ce, RHD*01N.01/01N.01, 
RHAG*532A/532A.6
Summary
The UK NRDP has been in existence for over 60 years to 
ensure that blood can be provided for specific patients with the 
rarest blood requirements. The combined approach of routine 
antigen typing and screening for high-prevalence antigens 
enables the vast majority of rare blood requests to be filled 
N.M. Thornton
Table 1. Testing performed through the rare donor screening 
program in South London
Specificity Antibody type Dilution Method
Coa Human 1:20 IAT
Ge Monoclonal 1:20 Saline
I Human 1:20 Saline
k Human 1:20 Saline
Kpb Monoclonal 1:150 IAT
Lub Monoclonal 1:20 Saline
Wrb Monoclonal 1:80 Saline
Vel Human 1:50 Papain
Lan Human 1:100 IAT
Yta Human 1:15 IAT
IAT = indirect antiglobulin test.
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within the UK and also provides us the opportunity to help 
other countries in need of rare blood that cannot be sourced 
locally.
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